November 19, 2026
Uncategorized

Lilly’s Donanemab gets CDSCO approval for early Alzheimer’s treatment (Soban News)

Eli Lilly has secured CDSCO marketing authorisation for donanemab, an amyloid-targeting therapy for adults with early symptomatic Alzheimer’s​Eli Lilly has secured CDSCO marketing authorisation for donanemab, an amyloid-targeting therapy for adults with early symptomatic Alzheimer’s ​Latest News [ SOBAN NEWS: International and National ]

Related posts

Women’s hockey camp eyes fitness boost, tactics ahead of WC 2026 campaign (Soban News)

News-Soban-Admin

WW II Navy veteran Ira ‘Ike’ Schab, Pearl Harbor survivor, dies at 105 (Soban News)

News-Soban-Admin

Maharashtra to become India’s semiconductor capital by 2030: Dhavse (Soban News)

News-Soban-Admin

Leave a Comment